Respiratory functional evaluation and pulmonary hyperinflation in asymptomatic smokers: Preliminary study

Area of Science:

• Pulmonary Medicine
• Respiratory Physiology
• Tobacco-Related Diseases

Background:

• Asymptomatic smokers without prior lung pathology often exhibit subtle respiratory changes.
• Tobacco use is a significant risk factor for multisystemic diseases, including pulmonary conditions.
• Early detection of subclinical pulmonary dysfunction in smokers is critical for intervention.

Purpose of the Study:

• To investigate respiratory function and lung hyperinflation in asymptomatic smokers.
• To identify tobacco-related diseases and their correlation with smoking habits and biomarkers.
• To assess premonitory anomalies indicative of future pulmonary disease in at-risk individuals.

Main Methods:

• A case-controlled study comparing asymptomatic smokers with healthy controls, matched for sex, age, and BMI.
• Smokers were recruited from a smoking cessation program with normal chest radiography.
• Respiratory function tests (spirometry, plethysmography) and urinary cotinine levels were analyzed.

Main Results:

• Smokers demonstrated reduced FEV1/FVC, FEF 75%, FEF 25-75%, and cardiothoracic index compared to controls.
• A significant inverse correlation was observed between total lung capacity (TLC) and smoking.
• 31.2% of smokers had extrapulmonary tobacco-related diseases, and 9.38% showed subclinical COPD.

Conclusions:

• Reduced pulmonary function parameters in asymptomatic smokers suggest early-stage lung dysfunction.
• Smoking cessation interventions are vital for this high-risk group due to multisystemic repercussions.
• This study highlights potential premonitory markers for COPD, warranting further investigation into reversibility post-cessation.